Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $649.51 million. The enterprise value is $617.25 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 126.86 million shares outstanding. The number of shares has decreased by -2.20% in one year.
| Current Share Class | 126.86M |
| Shares Outstanding | 126.86M |
| Shares Change (YoY) | -2.20% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 37.77% |
| Owned by Institutions (%) | 59.17% |
| Float | 55.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.29 |
| PS Ratio | 1.54 |
| Forward PS | 1.27 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 3.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.44 |
| EV / EBITDA | 194.96 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.95, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.95 |
| Quick Ratio | 2.94 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.70 |
| Debt / FCF | n/a |
| Interest Coverage | -35.48 |
Financial Efficiency
Return on equity (ROE) is -2.64% and return on invested capital (ROIC) is -2.34%.
| Return on Equity (ROE) | -2.64% |
| Return on Assets (ROA) | -2.01% |
| Return on Invested Capital (ROIC) | -2.34% |
| Return on Capital Employed (ROCE) | -3.68% |
| Revenue Per Employee | $494,282 |
| Profits Per Employee | -$17,937 |
| Employee Count | 869 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.64 |
Taxes
| Income Tax | -13.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.15% in the last 52 weeks. The beta is 1.77, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.77 |
| 52-Week Price Change | +74.15% |
| 50-Day Moving Average | 4.41 |
| 200-Day Moving Average | 3.98 |
| Relative Strength Index (RSI) | 62.50 |
| Average Volume (20 Days) | 712,810 |
Short Selling Information
The latest short interest is 9.80 million, so 7.72% of the outstanding shares have been sold short.
| Short Interest | 9.80M |
| Short Previous Month | 9.78M |
| Short % of Shares Out | 7.72% |
| Short % of Float | 17.66% |
| Short Ratio (days to cover) | 11.63 |
Income Statement
In the last 12 months, ORGO had revenue of $429.53 million and -$15.59 million in losses. Loss per share was -$0.12.
| Revenue | 429.53M |
| Gross Profit | 320.33M |
| Operating Income | -14.55M |
| Pretax Income | n/a |
| Net Income | -15.59M |
| EBITDA | 3.17M |
| EBIT | -14.55M |
| Loss Per Share | -$0.12 |
Full Income StatementBalance Sheet
The company has $73.08 million in cash and $40.82 million in debt, giving a net cash position of $32.26 million or $0.25 per share.
| Cash & Cash Equivalents | 73.08M |
| Total Debt | 40.82M |
| Net Cash | 32.26M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 361.22M |
| Book Value Per Share | 1.84 |
| Working Capital | 194.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.18 million and capital expenditures -$13.19 million, giving a free cash flow of -$46.37 million.
| Operating Cash Flow | -33.18M |
| Capital Expenditures | -13.19M |
| Free Cash Flow | -46.37M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
Gross margin is 74.58%, with operating and profit margins of -3.39% and -1.92%.
| Gross Margin | 74.58% |
| Operating Margin | -3.39% |
| Pretax Margin | -5.02% |
| Profit Margin | -1.92% |
| EBITDA Margin | 0.74% |
| EBIT Margin | -3.39% |
| FCF Margin | n/a |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.20% |
| Shareholder Yield | 2.20% |
| Earnings Yield | -2.40% |
| FCF Yield | -7.14% |
Analyst Forecast
The average price target for ORGO is $7.50, which is 46.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.50 |
| Price Target Difference | 46.48% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.82 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 1 |
